ReviewFrontiers in oncology2022

Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China.

Takaaki Mizuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.